Yilmaz Cigremis Selected Research

caffeic acid phenethyl ester

12/2021	Effects of caffeic acid phenethyl ester use and inhibition of p42/44 MAP kinase signal pathway on caveolin 1 gene expression and antioxidant system in chronic renal failure model of rats.
2/2006	Caffeic acid phenethyl ester (CAPE) attenuates cerebral vasospasm after experimental subarachnoidal haemorrhage by increasing brain nitric oxide levels.
7/2005	Myocardial ischemia/reperfusion-induced oxidative renal damage in rats: protection by caffeic acid phenethyl ester (CAPE).
5/2005	Ischemia-reperfusion leads to depletion of glutathione content and augmentation of malondialdehyde production in the rat heart from overproduction of oxidants: can caffeic acid phenethyl ester (CAPE) protect the heart?
12/2004	The protective effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in rat ovary.
4/2004	Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yilmaz Cigremis Research Topics

Disease

6	Ischemia 11/2007 - 07/2003
3	Body Weight (Weight, Body) 11/2018 - 03/2009
3	Ovarian Torsion 03/2010 - 09/2004
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2007 - 07/2005
3	Reperfusion Injury 12/2004 - 07/2003
2	Necrosis 01/2010 - 03/2009
1	Sleep Wake Disorders 05/2022
1	Renal Insufficiency (Renal Failure) 12/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2021
1	Cognitive Dysfunction 01/2021
1	Sepsis (Septicemia) 08/2020
1	Thrombosis (Thrombus) 01/2019
1	Cardiogenic Shock 01/2019
1	Myocardial Infarction 01/2019
1	Cardiomyopathies (Cardiomyopathy) 04/2006
1	Neoplasms (Cancer) 04/2006
1	Cardiotoxicity 04/2006
1	Intracranial Vasospasm 02/2006
1	Cataract (Cataracts) 02/2006
1	Coronary Occlusion 05/2005
1	Heart Injuries 05/2005
1	Proliferative Vitreoretinopathy 04/2004
1	Acute Kidney Injury (Acute Renal Failure) 09/2003

Drug/Important Bio-Agent (IBA)

6	caffeic acid phenethyl esterIBA 12/2021 - 04/2004
5	Malondialdehyde (Propanedial)IBA 12/2021 - 09/2004
5	Glutathione (Reduced Glutathione)IBA 12/2021 - 09/2004
4	MelatoninIBA 11/2007 - 07/2003
3	AntioxidantsIBA 12/2021 - 05/2005
3	salicylhydroxamic acid (SHAM)IBA 03/2010 - 07/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2006 - 07/2003
2	Free RadicalsIBA 11/2007 - 05/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2006 - 02/2006
2	ResveratrolIBA 02/2006 - 01/2004
2	Xanthine OxidaseIBA 12/2004 - 09/2004
1	Modafinil (Provigil)FDA Link 05/2022
1	CopperIBA 12/2021
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 12/2021
1	Caveolin 1IBA 12/2021
1	CatalaseIBA 12/2021
1	Phosphotransferases (Kinase)IBA 12/2021
1	Urea (Carbamide)FDA LinkGeneric 12/2021
1	CreatinineIBA 12/2021
1	NitrogenIBA 12/2021
1	Chloramphenicol O-Acetyltransferase (Chloramphenicol Acetyltransferase)IBA 12/2021
1	ZincIBA 12/2021
1	Superoxide DismutaseIBA 12/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	CaspasesIBA 08/2020
1	dexpanthenol (panthenol)FDA Link 08/2020
1	Therapeutic UsesIBA 08/2020
1	fibroblast growth factor 21IBA 11/2018
1	Messenger RNA (mRNA)IBA 01/2017
1	GhrelinIBA 01/2017
1	LeptinIBA 01/2017
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2010
1	EnzymesIBA 03/2009
1	antiarrhythmic peptide (AAP)IBA 03/2009
1	3-nitrotyrosineIBA 03/2009
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2006
1	AnthracyclinesIBA 04/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2006
1	pimagedine (aminoguanidine)IBA 04/2006
1	Sodium SeleniteIBA 02/2006
1	Selenious Acid (Selenite)IBA 02/2006
1	Oxidants (Oxidizing Agents)IBA 05/2005
1	EstersIBA 12/2004
1	caffeic acidIBA 12/2004
1	Cortisone FDA Link 04/2004
1	PolyphenolsIBA 01/2004
1	Amikacin (A.M.K)FDA LinkGeneric 09/2003

Therapy/Procedure

1	Ligation 08/2020
1	Punctures 08/2020
1	Stents 01/2019
1	Intraperitoneal Injections 03/2009
1	Drug Therapy (Chemotherapy) 04/2006
1	Slit Lamp 02/2006